
Successful Returns Management Starts With An Effective Returns Policy
Establishing a clear and consistent returns policy is an absolute requirement for any drug- or device-maker committed to successfully mitigating the financial liability attached to product flowing back through the supply chain.US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions
Inmar Intelligence, a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.
The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?
By Jason Murry, Senior Director, Healthcare Sales: Recent passage of the Lower Costs, More Transparency (LCMT) Act in a bipartisan vote by the U.S. House of Representatives is being heralded by the bill’s sponsors as “landmark legislation,” but is it really? The bill -- which is a long way from becoming law -- is focused on the very politically popular issue of lowering prescription drug prices for consumers. But where is the benefit for pharmacies?